Pharmacological effects of a new soluble guanylate cyclase stimulator in experimental pulmonary arterial hypertension
Aim. To assess the effect of an indolinone derivative (2-[2-[(5RS)-5-(hydroxymethyl)-3-methyl-1,3-oxazolidine-2yliden]-2-cyanoethylidene]-1H-indole-3(2H)-one (codename – GRS) on right ventricular contractility, endothelial vasodilator function, and histologic changes in the lungs and heart in a rat...
Saved in:
| Main Authors: | V. V. Bykov, A. V. Bykova, S. A. Stankevich, O. I. Aliev, A. V. Sidekhmenova, O. I. Dunaeva, V. A. Khazanov, A. I. Vengerovskii, V. V. Udut |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2023-04-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/5127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotic Activity of an Indolinone Derivative – a Soluble Guanylate Cyclase Stimulator
by: V. V. Bykov, et al.
Published: (2022-09-01) -
Analysis of research trends and development prospects of soluble guanylate cyclase stimulators/activators: using bibliometric methods
by: Bing Ju Yan, et al.
Published: (2025-06-01) -
Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets
by: Zh. D. Kobalava, et al.
Published: (2021-10-01) -
Soluble Guanylate Cyclase Stimulator, BAY41‐8543: A Promising Approach for the Treatment of Chronic Heart Failure Caused by Pressure and Volume Overload
by: Adriana Martišková, et al.
Published: (2025-04-01) -
Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
by: E. V. Filippov
Published: (2020-12-01)